Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120
- PMID: 1377948
- DOI: 10.1093/intimm/4.2.283
Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120
Abstract
Several motifs have been found to be the target of the neutralizing antibody response to HIV, the human immunodeficiency virus. One of the well characterized motifs maps to a loop within the third hypervariable region (V3) of the exterior envelope glycoprotein gp120 at amino acid positions 308-331 and is referred to as the principal neutralizing determinant (PND). The sequence of this V3 loop raises the question of the immunogenicity and the degree of diversity of the antibody response to the PND. We show here that this neutralization-related motif is highly immunogenic in HIV-positive subjects and in experimentally immunized primates and rodents submitted to various anti-HIV immunization regimens. In probing the diversity of the antibody response to PNDs corresponding to 11 HIV sequence-divergent isolates in serum samples of 101 HIV-positive individuals we found that human antibodies exhibit binding affinity to up to nine PND synthetic peptides. This antibody binding was in all cases tested inhibitable by the homologous PND synthetic peptide. We additionally demonstrate that this antibody cross-reactivity towards sequence-divergent PNDs is detectable in the sera of mice and chimpanzees experimentally immunized against a single HIV-1 isolate. Finally, we noticed that there is a hierarchy of reactivity among the various PNDs wherein the synthetic peptide corresponding to the MN isolate was generally the most prominently recognized by antibodies of human, non-human primate, and rodent origins. Based on these findings and on features of the sequences analyzed we suggest that, despite its overall sequence variability, the PND encompasses conserved amino acid positions or epitopes that are the targets of antibodies recognizing sequence-divergent isolates. We also propose that the high positive charge density of the most frequently recognized PNDs and the high antigenicity value of some of their residues are critical to the broad immunoreactivity of this neutralization-related motif.
Similar articles
-
Single peptide and anti-idiotype based immunizations can broaden the antibody response against the variable V3 domain of HIV-1 in mice.Mol Immunol. 1995 May;32(7):449-57. doi: 10.1016/0161-5890(95)00007-2. Mol Immunol. 1995. PMID: 7783749
-
Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23. doi: 10.1089/aid.1991.7.813. AIDS Res Hum Retroviruses. 1991. PMID: 1720628
-
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.AIDS Res Hum Retroviruses. 1994 May;10(5):577-83. doi: 10.1089/aid.1994.10.577. AIDS Res Hum Retroviruses. 1994. PMID: 7522494
-
[Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].Vestn Ross Akad Med Nauk. 1992;(9-10):47-52. Vestn Ross Akad Med Nauk. 1992. PMID: 1283721 Review. Russian.
-
HIV variability and perspectives for a vaccine.Vaccine. 1993;11(5):542-4. doi: 10.1016/0264-410x(93)90227-o. Vaccine. 1993. PMID: 8488707 Review.
Cited by
-
HIV-1 gp120 binding to dendritic cell receptors mobilize the virus to the lymph nodes, but the induced IL-4 synthesis by FcepsilonRI+ hematopoietic cells damages the adaptive immunity--a review, hypothesis, and implications.Virus Genes. 2004 Aug;29(1):147-65. doi: 10.1023/B:VIRU.0000032797.43537.d3. Virus Genes. 2004. PMID: 15215692 Review.
-
Controlling the HIV/AIDS epidemic: current status and global challenges.Front Immunol. 2012 Aug 14;3:250. doi: 10.3389/fimmu.2012.00250. eCollection 2012. Front Immunol. 2012. PMID: 22912636 Free PMC article.
-
Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens.Vaccine. 2013 Oct 1;31(42):4795-801. doi: 10.1016/j.vaccine.2013.07.085. Epub 2013 Aug 12. Vaccine. 2013. PMID: 23948230 Free PMC article.
-
Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity.Clin Exp Immunol. 1995 Mar;99(3):419-24. doi: 10.1111/j.1365-2249.1995.tb05567.x. Clin Exp Immunol. 1995. PMID: 7533680 Free PMC article.
-
Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.J Virol. 2006 Jun;80(11):5552-62. doi: 10.1128/JVI.02094-05. J Virol. 2006. PMID: 16699036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources